Another Alzheimer’s Vaccine Moves Closer to Human Trials
By Deborah Kan | December 31st, 2019
With repeated drug failures to treat Alzheimer’s disease in recent years, scientists are racing to find a vaccine to prevent the disease from evolving….
Tau Protein and Alzheimer’s: Does This Protein Hold the Key to a Cure?
By Being Patient | May 31st, 2019
Tau protein tangles (or neurofibrillary tangles) are a hallmark of Alzheimer’s disease, but what role do they play? First, you need to understand how…
Brain Scans Prevent Alzheimer’s Misdiagnosis and Lead to Better Treatment—But They’re Not Covered By Medicare
By Being Patient | April 2nd, 2019
An under-utilized tool could help correctly diagnose and manage dementia, leading to better care, according to a new study. The study, published in the…
Biogen Ends Late-Stage Alzheimer’s Trials, Crushing Hopes and Calling Amyloid Into Question
By Being Patient | March 21st, 2019
Clinical trial participants, researchers and investors were reeling on Thursday after Biogen and Eisai, its Japanese pharmaceutical partner, announced that they would be halting two…
A Vaccine for Alzheimer’s Shows Promise in Human Trial
By Being Patient | January 17th, 2019
A vaccine being tested in human patients by Dublin-based company United Neurosciences has shown promising results, according to a statement released by the company….
A Lapse in the Brain’s Security System Might Cause Alzheimer’s—And There’s a Drug to Help
By Being Patient | January 15th, 2019
A ‘leaky’ brain may be the first sign of Alzheimer’s in the brain—not the presence of beta-amyloid proteins or tau tangles, as researchers previously…
A Vaccine for Alzheimer’s: ‘We’re Getting Closer to Testing This Therapy in People’
By Being Patient | November 26th, 2018
What if you could get an Alzheimer’s vaccine like you do for measles or chickenpox? Scientists at University of Texas Southwestern Medical Center are…
Follow us